| ID | Sequence | Length | GC content |
|---|---|---|---|
| lnc-DAD1-2:5 | UUUUUGAGAAUCAUGAUGAGGCAUUAAAGAAGAGGAGGAGUGUCUCAAG… | 571 nt | 0.4378 |
| lnc-DAD1-2:6 | AUGAUGAGGCAUUAAAGAAGAGGAGGAGUGUCUCAAGGGAGGUGAGCUG… | 571 nt | 0.4956 |
| lnc-DAD1-2:7 | CUCGUCCCCUGCAGUCCUCAGGCAGCAGGCUGCCCUUCUGCAAUCAGUU… | 342 nt | 0.5088 |
| lnc-DAD1-2:8 | AGUUGUUACAGUUCUCAGUCCCCUAAGAGGCUGACCAAGUGCUGAGAGG… | 1768 nt | 0.4072 |
| lnc-DAD1-2:9 | AGUUGUUACAGUUCUCAGUCCCCUAAGAGGCUGACCAAGUGCUGAGAGG… | 1565 nt | 0.4064 |
No relevant information is available at the moment.
A study in humans identified the lnc-DAD1-2 as a long non-coding RNA that was down-regulated in peripheral blood mononuclear cells of patients with ST-elevation myocardial infarction compared to those with non-ST-elevation myocardial infarction, with a fold change of 4.49 [Zhong et al. DOI:10.1097/MD.0000000000013066].